Clinical Trial Update: Belatacept 3 Month Post Transplant Conversion Study [Phase 4]

View source ↗

Summary

A Phase 4 post-transplant study evaluating conversion to belatacept three months after kidney transplant has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebv-related Conditions
• Kidney Transplant Failure

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: Lorenzo Gallon | Conditions: Transplant; Failure, Kidney, EBV | Phase 4 | Status: COMPLETED | Results posted: 2021-09-08